Cui Xiaotian, Zhao Jinzhao, Zhou Xinda, Hua Ang, Chengxi, Tan Chen, and Han Wei Liu Ping, a 25-year-old living in Beijing, is queuing up outside the obesity clinic of the Peking University People’s Hospital early one morning, seeking a doctor’s prescription for the so-called “skinny jab” — a weight loss drug that has created a buying frenzy in China, where half the adults out of a total population of 1.4 billion are either overweight or obese.
Related Posts
Medanta Earning Growth: After a strong debut, can Medanta sustain gains? Earnings growth, retaining specialists will be key.
Last week, Global Health Ltd, the company which operates hospitals under the brand Medanta, made a strong debut on the…
Can Cipla make inhaled insulin a successful option for diabetes patients?
Umang Vohra, Global CEO, Cipla. Will Cipla’s big bet work?; image credit: Company. Synopsis Millions of diabetes patients have to…
A change of heart: inside a cardiac transplant — despair, doctor, donor, and a new life
Bhikaji Nirgun (on wheelchair), who underwent a heart transplant with Pravin Kulkarni (extreme left), the lead heart transplant surgeon at…
